| Product NDC: | 0085-1775 |
| Proprietary Name: | Cipro |
| Non Proprietary Name: | ciprofloxacin |
| Active Ingredient(s): | 500 mg/1 & nbsp; ciprofloxacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0085-1775 |
| Labeler Name: | Schering Plough Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021473 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090427 |
| Package NDC: | 0085-1775-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0085-1775-01) |
| NDC Code | 0085-1775-01 |
| Proprietary Name | Cipro |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0085-1775-01) |
| Product NDC | 0085-1775 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ciprofloxacin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090427 |
| Marketing Category Name | NDA |
| Labeler Name | Schering Plough Corporation |
| Substance Name | CIPROFLOXACIN |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |